PT3607962T - Angiotensina ii sozinha ou em combinação para o tratamento de hipotensão - Google Patents

Angiotensina ii sozinha ou em combinação para o tratamento de hipotensão

Info

Publication number
PT3607962T
PT3607962T PT191978667T PT19197866T PT3607962T PT 3607962 T PT3607962 T PT 3607962T PT 191978667 T PT191978667 T PT 191978667T PT 19197866 T PT19197866 T PT 19197866T PT 3607962 T PT3607962 T PT 3607962T
Authority
PT
Portugal
Prior art keywords
hypotension
angiotensin
alone
treatment
combination
Prior art date
Application number
PT191978667T
Other languages
English (en)
Portuguese (pt)
Original Assignee
The George Washington Univ A Congressionally Chartered Not For Profit Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53367119&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3607962(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The George Washington Univ A Congressionally Chartered Not For Profit Corporation filed Critical The George Washington Univ A Congressionally Chartered Not For Profit Corporation
Publication of PT3607962T publication Critical patent/PT3607962T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT191978667T 2013-12-18 2014-12-18 Angiotensina ii sozinha ou em combinação para o tratamento de hipotensão PT3607962T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361917576P 2013-12-18 2013-12-18
US201461955706P 2014-03-19 2014-03-19

Publications (1)

Publication Number Publication Date
PT3607962T true PT3607962T (pt) 2025-11-18

Family

ID=53367119

Family Applications (2)

Application Number Title Priority Date Filing Date
PT191978667T PT3607962T (pt) 2013-12-18 2014-12-18 Angiotensina ii sozinha ou em combinação para o tratamento de hipotensão
PT148726847T PT2986308T (pt) 2013-12-18 2014-12-18 Angiotensina ii combinada para o tratamento de hipotensão

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT148726847T PT2986308T (pt) 2013-12-18 2014-12-18 Angiotensina ii combinada para o tratamento de hipotensão

Country Status (25)

Country Link
US (7) US9220745B2 (enExample)
EP (2) EP3607962B1 (enExample)
JP (4) JP6824739B2 (enExample)
KR (4) KR20220028125A (enExample)
CN (4) CN106061493A (enExample)
AU (3) AU2014364528C1 (enExample)
BR (1) BR112016013961A2 (enExample)
CA (1) CA2933601A1 (enExample)
CY (1) CY1122604T1 (enExample)
DK (2) DK3607962T3 (enExample)
EA (1) EA037823B1 (enExample)
ES (1) ES2771749T3 (enExample)
FI (1) FI3607962T3 (enExample)
HR (1) HRP20200009T1 (enExample)
HU (1) HUE047062T2 (enExample)
IL (1) IL246162B (enExample)
LT (1) LT2986308T (enExample)
MX (2) MX380968B (enExample)
NZ (1) NZ721089A (enExample)
PL (1) PL2986308T3 (enExample)
PT (2) PT3607962T (enExample)
RS (1) RS59804B1 (enExample)
SI (1) SI2986308T1 (enExample)
SM (1) SMT202000018T1 (enExample)
WO (1) WO2015095535A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
BR112016013961A2 (pt) 2013-12-18 2017-10-10 The George Washington Univ A Congressional Chartered Not For Profit Corporation angiotensina ii sozinha ou em combinação para o tratamento da hipotensão
TW202214219A (zh) * 2014-07-08 2022-04-16 美商拉荷亞製藥公司 治療低血壓之方法
WO2016153558A1 (en) 2015-03-20 2016-09-29 Atkinson Arthur J Use of angiotensin ii (aii) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps
EP3400001A1 (en) * 2016-01-07 2018-11-14 La Jolla Pharmaceutical Company Methods of administering vasopressors
TW201733610A (zh) 2016-01-07 2017-10-01 拉荷亞製藥公司 投與血管收縮素ｉｉ之方法
WO2018191678A1 (en) * 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
US20190183962A1 (en) * 2017-12-15 2019-06-20 La Jolla Pharma, Llc Angiotensin compositions and methods related thereto
WO2023244552A1 (en) * 2022-06-15 2023-12-21 Virginia Commonwealth University Methods for fluid resuscitation of an organ donor
JP2025538841A (ja) * 2022-12-12 2025-11-28 プロレタリアート セラピューティクス， インコーポレイテッド 心損傷を処置する方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181008B (en) 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
US5216025A (en) * 1989-09-13 1993-06-01 Board Of Regents, The University Of Texas System Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
EP1401864A1 (en) 2001-06-04 2004-03-31 Human Genome Sciences Methods and compositions for modulating ace-2 activity
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
NO20034952D0 (no) 2003-11-06 2003-11-06 Amersham Health As Farmasöytiske forbindelser
EP1699495A2 (en) 2003-11-06 2006-09-13 Amersham Health AS Conjugates of angiotensin ii and an imaging moiety
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
WO2007040636A1 (en) 2005-09-29 2007-04-12 Fibrogen, Inc. Methods for reducing blood pressure
US20090304818A1 (en) 2005-12-30 2009-12-10 May Clive N Method of treatment
CA2655144A1 (en) 2006-06-15 2007-12-21 Gilead Colorado, Inc. Antihypertensive therapy method
WO2008130217A1 (en) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Cyclic angiotensin analogs
CN101795675A (zh) 2006-11-17 2010-08-04 达沃尔泰拉公司 使用具有Eudragit包衣的Zn/果胶珠粒进行的结肠递送
WO2009009907A1 (en) * 2007-07-18 2009-01-22 The University Of British Columbia Use of vasopressin-receptor agonists for the treatment of septic shock
EP2161030A1 (en) * 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof
AU2009319856A1 (en) 2008-11-28 2010-06-03 Abbvie Inc. Stable antibody compositions and methods for stabilizing same
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
FR2959414B1 (fr) * 2010-04-30 2016-01-08 Luc Quintin Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire
BR112013000744A2 (pt) 2010-07-14 2020-07-14 Cumberland Emerging Technologies, Inc uso de um antagonista de receptor de tromboxana a2 para prevenção ou tratamento de síndrome hepatorrenal,encefalopatia hepática,e doenças associadas
JP6522584B2 (ja) 2013-04-26 2019-05-29 ラ ホヤ ファーマシューティカル カンパニーＬａ Ｊｏｌｌａ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏｍｐａｎｙ 腎不全を処置するための組成物及び方法
BR112016013961A2 (pt) 2013-12-18 2017-10-10 The George Washington Univ A Congressional Chartered Not For Profit Corporation angiotensina ii sozinha ou em combinação para o tratamento da hipotensão
US20150286797A1 (en) 2014-04-02 2015-10-08 David R. Ratto System and method for administering medication
TW202214219A (zh) 2014-07-08 2022-04-16 美商拉荷亞製藥公司 治療低血壓之方法
EP3400001A1 (en) 2016-01-07 2018-11-14 La Jolla Pharmaceutical Company Methods of administering vasopressors
TW201733610A (zh) 2016-01-07 2017-10-01 拉荷亞製藥公司 投與血管收縮素ｉｉ之方法
WO2018191678A1 (en) 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
US20190183962A1 (en) 2017-12-15 2019-06-20 La Jolla Pharma, Llc Angiotensin compositions and methods related thereto

Also Published As

Publication number Publication date
LT2986308T (lt) 2020-03-25
EA037823B1 (ru) 2021-05-25
EP3607962B1 (en) 2025-08-13
PT2986308T (pt) 2020-01-21
KR20220028125A (ko) 2022-03-08
WO2015095535A9 (en) 2016-07-14
JP6824739B2 (ja) 2021-02-03
JP2025114753A (ja) 2025-08-05
JP2017501154A (ja) 2017-01-12
US10028995B2 (en) 2018-07-24
US20190328827A1 (en) 2019-10-31
SMT202000018T1 (it) 2020-03-13
RS59804B1 (sr) 2020-02-28
US11559559B2 (en) 2023-01-24
DK2986308T3 (en) 2020-01-27
US20230226141A1 (en) 2023-07-20
JP7175506B2 (ja) 2022-11-21
BR112016013961A2 (pt) 2017-10-10
HUE047062T2 (hu) 2020-04-28
US10493124B2 (en) 2019-12-03
AU2020277230A1 (en) 2020-12-24
NZ721089A (en) 2022-10-28
CN112546197A (zh) 2021-03-26
JP2022137224A (ja) 2022-09-21
CN111920939A (zh) 2020-11-13
US10765722B2 (en) 2020-09-08
KR20230051721A (ko) 2023-04-18
KR20240154702A (ko) 2024-10-25
EP3607962A1 (en) 2020-02-12
US20150164980A1 (en) 2015-06-18
HRP20200009T1 (hr) 2020-03-20
JP2019214610A (ja) 2019-12-19
CN106061493A (zh) 2016-10-26
DK3607962T3 (da) 2025-11-17
AU2014364528A9 (en) 2016-07-28
EP2986308A1 (en) 2016-02-24
MX2016008108A (es) 2017-03-09
KR102399383B1 (ko) 2022-05-19
PL2986308T3 (pl) 2020-05-18
EP2986308B1 (en) 2019-10-16
CA2933601A1 (en) 2015-06-25
AU2014364528A1 (en) 2016-06-30
CN119700926A (zh) 2025-03-28
AU2014364528C1 (en) 2021-01-07
IL246162A0 (en) 2016-07-31
EP2986308A4 (en) 2017-01-11
SI2986308T1 (sl) 2020-03-31
FI3607962T3 (fi) 2025-11-24
AU2014364528B2 (en) 2020-08-27
US20160129072A1 (en) 2016-05-12
US9220745B2 (en) 2015-12-29
EA201691258A1 (ru) 2016-11-30
ES2771749T3 (es) 2020-07-07
KR20160117437A (ko) 2016-10-10
MX2020011190A (es) 2020-11-13
IL246162B (en) 2020-03-31
US20220047669A1 (en) 2022-02-17
MX380968B (es) 2025-03-12
US20190070250A1 (en) 2019-03-07
WO2015095535A1 (en) 2015-06-25
AU2024219851A1 (en) 2024-10-10
US11096983B2 (en) 2021-08-24
US20180193407A1 (en) 2018-07-12
CY1122604T1 (el) 2021-03-12

Similar Documents

Publication Publication Date Title
GB2516814B (en) Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
PL3542798T3 (pl) Aceklidyna do zastosowania w leczeniu starczowzroczności
GB201321743D0 (en) Therapeutic agents
GB201321738D0 (en) Therapeutic Agents
IL246162B (en) Angiotensin II, alone or in combination, to treat low blood pressure
GB201321736D0 (en) Therapeutic agents
GB201321729D0 (en) Therapeutic agents
IL244014A0 (en) Combined therapy for the treatment of glioblastoma
GB201321728D0 (en) Therapeutic agents
GB201321733D0 (en) Therapeutic agents
GB201321730D0 (en) Therapeutic agents
GB201321739D0 (en) Therapeutic agents
GB201321741D0 (en) Therapeutic agents
GB201321740D0 (en) Therapeutic agents
GB201321732D0 (en) Therapeutic agents
GB201321734D0 (en) Therapeutic Agents
GB201321737D0 (en) Therapeutic Agents
GB201321742D0 (en) Therapeutic agents
GB201321735D0 (en) Therapeutic Agents
GB201321731D0 (en) Therapeutic agents
GB201304872D0 (en) Treatment
GB201317960D0 (en) Water treatment
GB201302839D0 (en) Water Treatment
GB201307310D0 (en) Treatment
ZA201604412B (en) Water treatment